SpringTide Ventures — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
Biotia develops infectious disease diagnostics using clinical metagenomic next-generation sequencing paired with artificial intelligence, offering diagnostic tests and genomics software for patients, providers, and health systems managing challenging infections.
AI & Machine LearningBiotechDigital Health
Chris Mason(Founder)inNiamh O'Hara(Founder & CEO)inNiamh B. O'Hara(Founder)in
Co-investorsCloquet Capital Partners, LLCDigitalDx VenturesEverywhere VenturesRed Bear VenturesSand Hill AngelsSeedToB+9 more
Source Defense provides a client-side security platform that detects and prevents digital skimming, Magecart attacks, and threats from third-party JavaScript on websites and payment pages.
CybersecurityEnterprise SoftwareSaaS
Co-investorsAllegisCyber CapitalConnecticut InnovationsBenhamou Global VenturesCapital One VenturesGlobal BrainJerusalem Venture Partners (JVP)+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.